GELS
Price
$0.73
Change
-$0.14 (-16.09%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
7.84M
Intraday BUY SELL Signals
HCM
Price
$10.15
Change
+$0.16 (+1.60%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.78B
41 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GELS vs HCM

GELS vs HCM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GELS vs. HCM commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GELS is a Hold and HCM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (GELS: $0.89 vs. HCM: $9.98)
Brand notoriety: GELS and HCM are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GELS: 6% vs. HCM: 116%
Market capitalization -- GELS: $9.53M vs. HCM: $1.8B
GELS [@Pharmaceuticals: Generic] is valued at $9.53M. HCM’s [@Pharmaceuticals: Generic] market capitalization is $1.8B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GELS’s FA Score shows that 1 FA rating(s) are green whileHCM’s FA Score has 1 green FA rating(s).

  • GELS’s FA Score: 1 green, 4 red.
  • HCM’s FA Score: 1 green, 4 red.
According to our system of comparison, GELS is a better buy in the long-term than HCM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GELS’s TA Score shows that 6 TA indicator(s) are bullish while HCM’s TA Score has 3 bullish TA indicator(s).

  • GELS’s TA Score: 6 bullish, 4 bearish.
  • HCM’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, GELS is a better buy in the short-term than HCM.

Price Growth

GELS (@Pharmaceuticals: Generic) experienced а -23.28% price change this week, while HCM (@Pharmaceuticals: Generic) price change was -7.89% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.70%. For the same industry, the average monthly price growth was +0.08%, and the average quarterly price growth was +8.31%.

Reported Earning Dates

HCM is expected to report earnings on Aug 03, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.70% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HCM($1.78B) has a higher market cap than GELS($7.84M). GELS YTD gains are higher at: 11.238 vs. HCM (-25.169). HCM has higher annual earnings (EBITDA): 38M vs. GELS (-1.6M). HCM has higher revenues than GELS: HCM (602M) vs GELS (0).
GELSHCMGELS / HCM
Capitalization7.84M1.78B0%
EBITDA-1.6M38M-4%
Gain YTD11.238-25.169-45%
P/E RatioN/A3.77-
Revenue0602M-
Total CashN/A1.37B-
Total DebtN/A93.4M-
FUNDAMENTALS RATINGS
HCM: Fundamental Ratings
HCM
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
20
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GELSHCM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
75%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 8 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
GELS
Daily Signal:
Gain/Loss:
HCM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SOLC14.480.64
+4.65%
Canary Marinade Solana ETF
IGPT108.111.71
+1.61%
Invesco AI and Next Gen Software ETF
ITWO46.570.43
+0.93%
ProShares Russell 2000 High Income ETF
HSMV37.430.05
+0.15%
First Trust Horizon Managed Vol S/M ETF
MLPB28.10-0.05
-0.18%
UBS ETRACS Alerian MLPInfrs ETN SerB

GELS and

Correlation & Price change

A.I.dvisor tells us that GELS and SXTC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GELS and SXTC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GELS
1D Price
Change %
GELS100%
-14.43%
SXTC - GELS
25%
Poorly correlated
+7.17%
HCM - GELS
24%
Poorly correlated
-2.97%
AMLX - GELS
23%
Poorly correlated
+3.89%
IRWD - GELS
23%
Poorly correlated
+7.77%
EVO - GELS
22%
Poorly correlated
+2.34%
More

HCM and

Correlation & Price change

A.I.dvisor tells us that HCM and ACET have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HCM and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCM
1D Price
Change %
HCM100%
-2.97%
ACET - HCM
29%
Poorly correlated
+1.60%
TLRY - HCM
27%
Poorly correlated
-2.96%
CGC - HCM
27%
Poorly correlated
-0.85%
GELS - HCM
25%
Poorly correlated
-14.43%
BHC - HCM
25%
Poorly correlated
-2.10%
More